High incidence of factor v Leiden and prothrombin G20210A in healthy southern Italians

Clinical and Applied Thrombosis/Hemostasis

Volumn 15, Issue 3, 2009, Pages 356-359

  Sottilotta, Gianluca ^a   Mammì, Corrado ^a   Furlò, Giuseppe ^a   Oriana, Vincenzo ^a   Latella, Caterina ^a   Trapani Lombardo, Vincenzo ^a  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

Factor V Leiden; Prothrombin G20210; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; ITALY; MALE; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR V; FEMALE; GENE FREQUENCY; HETEROZYGOTE; HOMOZYGOTE; HUMANS; ITALY; MALE; POLYMORPHISM, GENETIC; PROTHROMBIN; REFERENCE VALUES;

EID: 66249096340     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607310218     Document Type: Article

References (18)

1. Marz W., Nauck M., Wieland H. The molecular mechanism of inherited thrombophilia. Z Kardiol. 2000 ; 89: 575-586.
2. Bertina RM, Koeleman BP, Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994 ; 369: 64-67.
3. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM A common genetic variation in the 3ĝ€2-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996 ; 88: 3698-3703.
4. Ridker PM, Miletich JP, Stampfer MJ, et al. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation. 1995 ; 92: 2800-2802.
5. Brown K., Luddington R., Williamson D., Baker P., Baglin T. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3ĝ€2-untranslated region of the prothrombin gene. Br J Haematol. 1997 ; 98: 907-909.
6. Burzotta F., Paciaroni K., De Stefano V., et al. Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease. Eur Heart J. 2002 ; 23: 26-30.
7. Cox MJ, Rees DC, Martinson JJ, Clegg JB Evidence for a single origin of factor V Leiden. Br J Haematol. 1996 ; 92: 1022-1025.
8. Zivelin A., Rosenberg N., Faier S., et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood. 1998 ; 92: 1119-1124.
9. Rees DC The population genetics of factor V Leiden (Arg506Gln). Br J Haematol. 1996 ; 95: 579-586.
10. Rosendaal FR, Doggen CJ, Zivelin A., et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998 ; 79: 706-708.
11. Rosen E., Renbaum P., Heyd J., Levy-Lahad E. High frequency of factor V Leiden in a population of Israeli Arabs. Thromb Haemost. 1999 ; 82: 1768.
12. Irani-Hakime N., Tamim H., Elias G., Finan RR, Daccache JL, Almawi WY High prevalence of factor V mutation (Leiden) in the Eastern Mediterranean. Clin Chem. 2000 ; 46: 134-136.
13. Angelopoulou K., Nicolaides A., Constantinou Deltas C. Prevalence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population. Clin Appl Thromb Hemost. 2000 ; 6: 104-107.
14. Tamim H., Finan RR, Almawi WY Prevalence of two thrombophilia predisposing mutations: factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese. Thromb Haemost. 2002 ; 88: 691-692.
15. Frere C., Saut N., Boukef MK, Zili M., Toumi NEH. Factor V Leiden G1691A and prothrombin G20210A mutations are common in Tunisia. J Thromb Haemost. 2003 ; 1: 2541-2542.
16. Mathonnet F., Nadifi S., Serazin-Leroy V., Dakouane M., Giudicelli Y. Absence of factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy Moroccan population. Thromb Haemost. 2002 ; 88: 1073-1074.
17. Cavalli-Sforza LL, Menozzi P., Piazza A. Demic expansions and human evolution. Science. 1993 ; 259: 639-646.
18. Mannucci PM Genetic hypercoagulability: prevention suggests testing family members. Blood. 2001 ; 98: 21-22.